Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors
Journal Article
Overview
publication date
- March 1, 2022
has subject area
- Biochemical Phenomena - Acetylation
- Carrier Proteins - Histones
- Enzymes - Histone Deacetylase 1
- Enzymes - Histone Deacetylase 1
- Histone Deacetylase Inhibitors
- Histone Deacetylases
- Histone Deacetylases - Histone Deacetylase 1
- Histone Deacetylases - Histone Deacetylase 1
- Humans
- Metabolism - Acetylation
- Neoplasms
- Nuclear Proteins - Histones
- Nucleoproteins - Histones
- Organic Chemistry Phenomena - Acetylation
has restriction
- bronze
Date in CU Experts
- March 25, 2022 10:26 AM
Full Author List
- Diamond JR; Pitts TM; Ungermannova D; Nasveschuk CG; Zhang G; Phillips AJ; Bagby SM; Pafford J; Yacob BW; Newton TP
author count
- 20
citation count
- 8
published in
- Molecular Cancer Therapeutics Journal
Other Profiles
International Standard Serial Number (ISSN)
- 1535-7163
Electronic International Standard Serial Number (EISSN)
- 1538-8514
Digital Object Identifier (DOI)
Additional Document Info
start page
- 397
end page
- 406
volume
- 21
issue
- 3